Evaluation of Letrozole and Methotrexate in the Management of Ectopic Pregnancy – A Randomized Clinical Trial Study

Background: Ectopic pregnancy (EP) is one of the critical health conditions worldwide. Letrozole, an aromatase inhibitor that suppresses peripheral conversion of androgens to estrogens, has recently been introduced as a low-cost and minimal side effects treatment for EP. We studied the use of the le...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Farahnaz Mardanian, Faeze Ghasemi, Ferdous Mehrabian, Shamim Ghobadi, Safora Roholamin, Maryam Haji Hashemi
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wolters Kluwer Medknow Publications 2025-12-01
Saila:	Advanced Biomedical Research
Gaiak:	anti-mullerian hormone aromatase inhibitors beta human chorionic gonadotropin ectopic pregnancy letrozole methotrexate
Sarrera elektronikoa:	https://journals.lww.com/10.4103/abr.abr_530_24
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!